-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Orchestra BioMed Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2022 to Q2 2024.
- Orchestra BioMed Holdings, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $44K, a 18.5% decline year-over-year.
- Orchestra BioMed Holdings, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $166K, a 19.8% decline year-over-year.
- Orchestra BioMed Holdings, Inc. annual Cost of Revenue for 2023 was $186K, a 11.8% decline from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)